Correlation Between Visa and Orient Pharma

Can any of the company-specific risk be diversified away by investing in both Visa and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Orient Pharma Co, you can compare the effects of market volatilities on Visa and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Orient Pharma.

Diversification Opportunities for Visa and Orient Pharma

0.81

Correlation Coefficient

Visa  Orient Pharma

Very poor diversification

The 3 months correlation between Visa and Orient is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of Visa i.e., Visa and Orient Pharma go up and down completely randomly.

Pair Corralation between Visa and Orient Pharma

Taking into account the 90-day investment horizon Visa is expected to generate 2.95 times less return on investment than Orient Pharma. But when comparing it to its historical volatility, Visa Class A is 2.8 times less risky than Orient Pharma. It trades about 0.09 of its potential returns per unit of risk. Orient Pharma Co is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  2,425  in Orient Pharma Co on September 24, 2024 and sell it today you would earn a total of  1,275  from holding Orient Pharma Co or generate 52.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	99.4%
Values	Daily Returns

Visa Class A  vs.  Orient Pharma Co

Visa Class A

Risk-Adjusted Performance

17 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.

Orient Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Visa and Orient Pharma

The main advantage of trading using opposite Visa and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.

The idea behind Visa Class A and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.